Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred H J Kim

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Lancet. Rheumatology|May 11, 2024
Additional SARS-CoV-2 vaccine doses: a little is better than noneAlfred H J Kim
The Journal of Rheumatology|February 1, 2024
Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a CatchAlfred H J Kim
Annals of Internal Medicine|April 2, 2020
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should KnowJinoos Yazdany, Alfred H J Kim
The Journal of Rheumatology|January 15, 2023
The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for TherapeuticsAnuja Java, Alfred H J Kim
Rheumatic Diseases Clinics of North America|July 3, 2021
Systemic Lupus Erythematosus: The Next Generation of Ideas and ScientistsAlfred H J Kim, Zahi Touma
The Lancet. Rheumatology|September 28, 2020
The contribution of the observational research design to COVID-19 researchAlfred H J Kim, Seth A Eisen
The Lancet. Rheumatology|May 9, 2022
Immunosuppression and SARS-CoV-2 breakthrough infectionsAlfred H J Kim, Jeffrey A Sparks
Rheumatic Diseases Clinics of North America|November 26, 2013
Cardiac manifestations of systemic lupus erythematosusJonathan J Miner, Alfred H J Kim
Best Practice & Research. Clinical Rheumatology|February 21, 2021
Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic diseasePhilip C Robinson, Alfred H J Kim
JAMA Internal Medicine|December 28, 2021
COVID-19 Breakthrough Infection Among Immunocompromised PersonsAlfred H J Kim, Mary C Nakamura
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Lancet. Rheumatology|May 11, 2024
Additional SARS-CoV-2 vaccine doses: a little is better than noneAlfred H J Kim
The Journal of Rheumatology|February 1, 2024
Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a CatchAlfred H J Kim
Annals of Internal Medicine|April 2, 2020
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should KnowJinoos Yazdany, Alfred H J Kim
The Journal of Rheumatology|January 15, 2023
The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for TherapeuticsAnuja Java, Alfred H J Kim
Rheumatic Diseases Clinics of North America|July 3, 2021
Systemic Lupus Erythematosus: The Next Generation of Ideas and ScientistsAlfred H J Kim, Zahi Touma
The Lancet. Rheumatology|September 28, 2020
The contribution of the observational research design to COVID-19 researchAlfred H J Kim, Seth A Eisen
The Lancet. Rheumatology|May 9, 2022
Immunosuppression and SARS-CoV-2 breakthrough infectionsAlfred H J Kim, Jeffrey A Sparks
Rheumatic Diseases Clinics of North America|November 26, 2013
Cardiac manifestations of systemic lupus erythematosusJonathan J Miner, Alfred H J Kim
Best Practice & Research. Clinical Rheumatology|February 21, 2021
Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic diseasePhilip C Robinson, Alfred H J Kim
JAMA Internal Medicine|December 28, 2021
COVID-19 Breakthrough Infection Among Immunocompromised PersonsAlfred H J Kim, Mary C Nakamura
Pageof 7